Tag: Kuvan

Phenylketonuria (PKU), an inherited metabolic disorder, affects approximately 1 in 10,000 to 15,000 newborns in the United States, necessitating lifelong management to control phenylalanine levels. For individuals with PKU, learning how to reduce phenylalanine levels is critical to prevent severe health and cognitive complications.

According to the National Institutes of Health, untreated phenylketonuria (PKU) can lead to intellectual disability and other health problems, emphasizing the need for effective management. Controlling the amount of this essential amino acid is critical, and knowing what lowers phenylalanine is the first step toward successful treatment.

Did you know that in the U.S., approximately 1 in 25,000 newborns are diagnosed with phenylketonuria (PKU), a rare genetic disease? For those with this condition, learning how to get phenylalanine out of your system—or more accurately, manage its levels—is crucial for preventing serious lifelong health complications.